Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Zensun (Shanghai) Sci & Tech Co. logo — Healing through innovation, delivering life-saving therapies...

Zensun (Shanghai) Sci & Tech Co.

Healing through innovation, delivering life-saving therapies for the unmet needs of tomorrow

Founded 2000 Venture round Total: $507.00M Biopharma, Biotechnology

General Information

Company Name Zensun (Shanghai) Sci & Tech Co.
Founded Year 2000
Industries Biopharma, Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Zensun (Shanghai) Sci & Tech Co.. To contact Zensun (Shanghai) Sci & Tech Co., visit zensunus.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Zensun (Shanghai) Sci & Tech Co. compare?

A PDF of Zensun (Shanghai) Sci & Tech Co. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Zensun (Shanghai) Sci & Tech Co. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Zensun (Shanghai) Sci & Tech Co.

Zensun (Shanghai) Sci & Tech Co. is a biopharmaceutical and biotechnology company founded in 2000, dedicated to developing innovative bio-therapeutic products to address serious and life-threatening unmet medical needs. The company's slogan "Healing through innovation, delivering life-saving therapies for the unmet needs of tomorrow" reflects its commitment. Zensun focuses on discovering new medicines through novel disease-specific targets and advanced technologies, with patented discoveries developed into therapeutic solutions. The company's last investment of CNY507.00M in a Venture Round was secured on 16 November 2017 and included investments from SDIC Fund Management, Orient Securities, China Everbright Ivy Capital Investment, TFTR Investment, and China Venture Capital. Zensun's current pipeline includes treatments for cardiovascular disease, anti-cancer drugs, and therapies for energy metabolism disorders, aligning with its mission of providing life-altering treatments that target the root causes of conditions like heart failure and cancer. With a focus on addressing unmet medical needs, Zensun is poised to make a significant impact on patient outcomes and the broader healthcare industry.

Business keywords: biopharmaceutical, innovation, therapeutic products, cardiovascular disease, anti-cancer drugs, energy metabolism disorders, life-saving therapies, novel disease-specific targets, patented discoveries, advanced technologies, unmet medical needs, heart failure, cancer treatments

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round CNY507.00M 5
SDIC Fund Management Orient Securities
SDIC Fund Management, Orient Securities +3
16 Nov 2017

Zensun (Shanghai) Sci & Tech Co. Alternatives & Competitors

View All Alternatives
Zensun (Shanghai) Sci & Tech Co. vs
Myogen
Myogen

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.

Series D
Biopharma, Biotechnology
Zensun (Shanghai) Sci & Tech Co. vs
Yuanyin Bio
Yuanyin Bio

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clinical needs...

Series A
Biopharma, Biotechnology
Zensun (Shanghai) Sci & Tech Co. vs
Faron
Faron Finland

A CLEVER Approach to Fight Cancer.

Post-IPO Debt
60 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Zensun (Shanghai) Sci & Tech Co.

Healing through innovation, delivering life-saving therapies for the unmet needs of tomorrow
Zensun (Shanghai) Sci & Tech Co. was founded in 2000.
Zensun (Shanghai) Sci & Tech Co. operates in Biopharma and Biotechnology. Its work centres on biopharmaceutical, innovation, therapeutic products and cardiovascular disease.
Zensun (Shanghai) Sci & Tech Co. has completed 1 funding round, raising a total of $507.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Zensun (Shanghai) Sci & Tech Co. include Myogen, Yuanyin Bio, Faron, Granza Bio, Ocera Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zensun (Shanghai) Sci & Tech Co. and Myogen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Zensun (Shanghai) Sci & Tech Co., https://bouncewatch.com/company/zensun-shanghai-sci-tech-co, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout